Total Payments
$1,574
2019 Payments
$21.43
Companies
18
Transactions
104
Medicare Patients
13
Medicare Billing
$1,319
Payment Breakdown by Category
Food & Beverage$1,567 (99.5%)
Education$7.68 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,567 | 101 | 99.5% |
| Education | $7.68 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $364.75 | 19 | $0 (2019) |
| Depomed, Inc. | $231.42 | 10 | $0 (2017) |
| Daiichi Sankyo Inc. | $153.54 | 13 | $0 (2017) |
| Collegium Pharmaceutical, Inc. | $145.12 | 12 | $0 (2018) |
| Novo Nordisk Inc | $139.80 | 10 | $0 (2018) |
| Purdue Pharma L.P. | $129.18 | 8 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $72.23 | 7 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $71.86 | 5 | $0 (2018) |
| BioDelivery Sciences International, Inc. | $51.43 | 4 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $49.77 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $21.43 | 1 | Supernus Pharmaceuticals, Inc. ($21.43) |
| 2018 | $222.68 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($49.77) |
| 2017 | $1,330 | 85 | Supernus Pharmaceuticals, Inc. ($305.05) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/09/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: AED | ||||||
| 10/17/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $10.82 | General |
| Category: AED | ||||||
| 07/17/2018 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.13 | General |
| Category: Opioid Analgesic | ||||||
| 06/26/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 06/13/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: DIABETES | ||||||
| 06/12/2018 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: DUEXIS | ||||||
| 06/06/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: AED | ||||||
| 05/27/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.95 | General |
| Category: AED | ||||||
| 05/23/2018 | Collegium Pharmaceutical, Inc. | XTAMPZAER (Drug) | Food and Beverage | Cash or cash equivalent | $12.64 | General |
| Category: Opioid Analgesic | ||||||
| 05/09/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/09/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: Central Nervous System (CNS) | ||||||
| 04/19/2018 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Lower GI | ||||||
| 02/27/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Diabetes | ||||||
| 01/29/2018 | Purdue Pharma L.P. | OXYCONTIN (Drug), SYMPROIC, HYSINGLA ER | Food and Beverage | Cash or cash equivalent | $13.94 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.73 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/22/2018 | BioDelivery Sciences International, Inc. | BUNAVAIL 2.1 mg 30-count box (Drug), BUNAVAIL 2.1 mg single pouch, BUNAVAIL 4.2 mg 30-count box | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Addiction Therapy | ||||||
| 01/22/2018 | BioDelivery Sciences International, Inc. | BUNAVAIL 2.1 mg 30-count box (Drug), BUNAVAIL 2.1 mg single pouch, BUNAVAIL 4.2 mg 30-count box | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Addiction Therapy | ||||||
| 12/11/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.88 | General |
| 12/05/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.26 | General |
| Category: AED | ||||||
| 12/01/2017 | Depomed, Inc. | Nucynta (Drug), Zipsor | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: Pain | ||||||
| 11/30/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/30/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.73 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/22/2017 | Collegium Pharmaceutical, Inc. | Xtampza ER (Drug) | Food and Beverage | Cash or cash equivalent | $9.01 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 13 | 23 | $4,210 | $1,319 |
Total Patients
13
Total Services
23
Medicare Billing
$1,319
Procedure Codes
1
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 23 | $4,210 | $1,319 | 31.3% |
About Dr. Benjamin Fore, DO
Dr. Benjamin Fore, DO is a Pain Medicine healthcare provider based in Ardmore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922063510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Fore, DO has received a total of $1,574 in payments from pharmaceutical and medical device companies, with $21.43 received in 2019. These payments were reported across 104 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,567).
As a Medicare-enrolled provider, Fore has provided services to 13 Medicare beneficiaries, totaling 23 services with total Medicare billing of $1,319. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Ardmore, OK
- Active Since 04/18/2006
- Last Updated 04/15/2016
- Taxonomy Code 208VP0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922063510
Products in Payments
- TROKENDI XR (Drug) $343.32
- Nucynta (Drug) $231.42
- Movantik (Drug) $153.54
- Xtampza ER (Drug) $115.35
- Trintellix (Drug) $102.20
- BELSOMRA (Drug) $71.86
- Victoza (Drug) $56.72
- BUNAVAIL 2.1 mg 30-count box (Drug) $51.43
- HYSINGLA ER (Drug) $47.48
- FARXIGA (Drug) $31.79
- VIBERZI (Drug) $28.67
- OXTELLAR XR (Drug) $21.43
- Saxenda (Drug) $20.23
- BUTRANS (Drug) $19.96
- Amitiza (Drug) $19.80
- POC cobas Liat Analyzer, Assays, Controls and Accessories (Device) $18.00
- Levemir (Drug) $17.60
- XTAMPZA (Drug) $17.13
- XIFAXAN (Drug) $15.56
- JARDIANCE (Drug) $15.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.